RIBOZYME PHARMACEUTICALS, INC.
Patent Owner
Stats
- 34 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Nov 24, 2005 most recent publication
Details
- 34 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 6,210 Total Citation Count
- Sep 25, 1989 Earliest Filing
- 135 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2003/0143,708 Method and reagent for the treatment of alzheimer's diseaseDec 20, 00Jul 31, 03[A61K, C07H, C12P, C12N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6686463 Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivativesAug 31, 01Feb 03, 04[C07H]
6673611 Nucleic acid molecules with novel chemical compositions capable of modulating gene expressionMay 25, 01Jan 06, 04[C07H, C12Q, C12P, C12N]
6586238 Enzymatic nucleic acids containing 5'-and or 3'-cap structuresOct 15, 99Jul 01, 03[C07H, C12N]
6509460 Nucleoside triphosphates and their incorporation into oligonucleotidesAug 23, 00Jan 21, 03[C07H]
6489465 Xylofuranosly-containing nucleoside phosphoramidites and polynucleotidesSep 21, 01Dec 03, 02[C07H, C12Q, A01N]
6469158 Synthesis, deprotection, analysis and purification of RNA and ribozymesMay 02, 95Oct 22, 02[C07H]
6395713 Compositions for the delivery of negatively charged moleculesJul 21, 98May 28, 02[A61K, A01N, C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2005/0261,212 RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering RNAAbandonedJul 26, 02Nov 24, 05[A61K, C12N]
2005/0074,760 Enzymatic nucleic acids containing 5'-and/or 3'-cap structuresAbandonedMay 06, 03Apr 07, 05[C07H, A61K, C12Q, C12N]
2004/0102,389 Nucleic acid-mediated treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)AbandonedNov 04, 02May 27, 04[A61K, C12N]
2004/0033,568 Method and reagent for treatment of diseases caused by expression of the c-myc geneAbandonedDec 18, 02Feb 19, 04[C07H]
2004/0023,292 Method and reagent for the detection of proteins and peptidesAbandonedOct 18, 02Feb 05, 04[C12P, G01N, G06F]
2003/0207,837 Method and reagent for the induction of graft tolerance and reversal of immune responsesAbandonedMay 19, 03Nov 06, 03[C07H, A61K, C12N]
2003/0203,870 Method and reagent for the inhibition of NOGO and NOGO receptor genesAbandonedMay 06, 03Oct 30, 03[A61K, C07H]
2003/0191,077 Method and reagent for the treatment of asthma and allergic conditionsAbandonedAug 28, 02Oct 09, 03[A61K, C07H, C12Q, C12N]
2003/0186,909 Nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptorsAbandonedOct 21, 02Oct 02, 03[A61K, C07H]
2003/0186,923 Method and reagent for inhibiting P-glycoprotein (mdr-1 gene)AbandonedMay 15, 03Oct 02, 03[A61K, C07H, C12N]
2003/0175,950 RNA interference mediated inhibition of HIV gene expression using short interfering RNAAbandonedAug 21, 02Sep 18, 03[C07H, A61K, C12P]
2003/0170,644 Method for screening nucleic acid catalystsAbandonedMar 29, 02Sep 11, 03[C07H, C12Q, C12P]
2003/0171,311 Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infectionAbandonedMar 26, 01Sep 11, 03[A61K, C07H]
2003/0153,521 Nucleic acid treatment of diseases or conditions related to levels of RasAbandonedSep 10, 02Aug 14, 03[A61K, C12Q, C12N]
2003/0143,732 RNA interference mediated inhibition of adenosine A1 receptor (ADORA1) gene expression using short interfering RNAAbandonedAug 20, 02Jul 31, 03[C07H, C12N]
2003/0140,362 In vivo models for screening inhibitors of hepatitis B virusAbandonedOct 24, 02Jul 24, 03[C12Q, A01K, G01N]
2003/0134,806 Method and reagent for the inhibition of gridAbandonedFeb 23, 01Jul 17, 03[A61K, C07H]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.